The Clinical Impact of the Novel Alzheimer's Blood-based Biomarkers

NCT06246019 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Cognitive Impairment
Dementia
Neurodegenerative Diseases
Frontotemporal Dementia
Lewy Body Disease
Vascular Dementia

Interventions

DIAGNOSTIC_TEST: Early adoption of blood-based biomarkers for Alzheimer's disease

Sponsor

Hospital del Mar Research Institute (IMIM)